News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shukla Sath
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Shukla Sath (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 266,000 shares
@ $0 |
|
| 02/03/2023 |
4
| Shukla Sath (CFO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 265,957 shares
@ $0
Sold 9,504 shares
@ $1.8279, valued at
$17.4k
|
|
| 08/30/2022 |
4
| Shukla Sath (CFO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 6,017 shares
@ $0.8938, valued at
$5.4k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/31/2020 |
4
| Shukla Sath (EVP, CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 80,500 shares
@ $0
Granted 123,900 options to buy
@ $4.21, valued at
$521.6k
|
|
| 07/24/2019 |
4
| Shukla Sath (EVP, CFO) has filed a Form 4 on ZIOPHARM ONCOLOGY INC|
Txns:
| Granted 400,000 options to buy
@ $5.6, valued at
$2.2M
|
|
| 07/24/2019 |
3
| Shukla Sath (EVP, CFO) has filed a Form 3 on ZIOPHARM ONCOLOGY INC |
|
|